Refresh

This website therichardrosereport.com/downloads/fda-cannabis-and-cannabis-derived-compounds-quality-considerations-for-clinical-research-draft-guidance-for-industry/ is currently offline. Cloudflare's Always Online™ shows a snapshot of this web page from the Internet Archive's Wayback Machine. To check for the live version, click Refresh.

FDA: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Draft Guidance for Industry

From FDA, dated July 16, 2020: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Draft Guidance for Industry. 9 Pages, FREE, by FDA.